The Florence Effect Calls for Nominations!
On Florence Nightingale’s 200th birthday, the legacy of the trailblazing nurse has never been so relevant-as health care workers and researchers across the globe continue to battle against the COVID-19 pandemic.
In an effort to celebrate, honor and connect clinical research workers during this time, Florence Healthcare is calling for nominations of inspiring clinical researcher professionals in an initiative called The Florence Effect. For each nomination, the Florence Effect will make a donation to Greater Gift, and the individual with the most votes will receive a $500 American Express gift card.
Florence hopes this initiative will serve as a platform to appreciate deserving clinical researchers and offer support and encouragement during this challenging time for health care.
You can nominate as many individuals as you’d like, and vote up to 10 times per day.
Get more information here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
